Alliance Pharma AIM Listing Canceled After 拢362M Takeover
Consumer healthcare company Alliance Pharma PLC said Thursday that it has canceled its share trading on London's junior AIM market following its 拢362 million ($481 million) takeover by a consortium that...To view the full article, register now.
Already a subscriber? Click here to view full article